AMSC vs BSX · P/E 14, rev $299.2M vs P/E 20, rev $10.65B
American Superconductor Corporation (AMSC) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
American Superconductor Corporation (AMSC) is a specialty industrial machinery company listed on US.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Latest reported AMSC revenue for 2026-03-31 was $299.2M. Net income was $133.8M. Revenue was up 34.3% from 2025-03-31 to 2026-03-31. AMSC currently screens at market cap $2.02B and trailing P/E 13.9.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
AMSC currently screens at market cap $2.02B and trailing P/E 13.9. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the AMSC and BSX stock pages for the full models.
Not investment advice.